InsidersTradesSigma
Track the Qiagen N.V. stock price and the full insider trade history of the company, a publicly traded company based in Netherlands. Shares trade on the NL market, under the authority of AFM. Operating in the Health Care sector, Qiagen N.V. has published 349 public disclosures. Market capitalisation: €8.9bn. The latest transaction was filed on 11 August 2026 (Purchase). Among the most active insiders: R. Sackers. The full history is free.
349
Insider Decl.
n/a
Thresholds
€1bn
91 ops.
Buy Volume
€187m
95 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Qiagen N.V. Buy (bullish), based on 14 analysts. Average price target: US$46.07.
25Σ signal
Fundamental score
Ranked 8,313 of 29,016 companies
62.1
score / 100
Value55
Quality69
FCF yld5.0%
Earn yld4.8%
EV/EBITDA14.9x
ROE12%
Gross mgn62%
Net mgn20%
Debt/EBITDA2.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 11 August 2026
Declarations349 total
29,150 sharesGewoon aandeelAFM:193942
60,000 sharesGewoon aandeelAFM:193511
-4,705 sharesRestricted share awardAFM:188999
-900 sharesRestricted share awardAFM:188993
-119,695 sharesRestricted share awardAFM:188984
-5,990 sharesRestricted share awardAFM:189031
-67,723 sharesRestricted share awardAFM:188955
-5,990 sharesRestricted share awardAFM:189028
-9,156 sharesRestricted share awardAFM:189030
-5,990 sharesRestricted share awardAFM:189026
4,618 sharesRestricted share awardAFM:189015
4,618 sharesRestricted share awardAFM:189013
70,305 sharesRestricted share awardAFM:189016
4,618 sharesRestricted share awardAFM:189005
4,618 sharesRestricted share awardAFM:189011
4,618 sharesRestricted share awardAFM:189014
25 of 349 declarations
About Qiagen N.V.
Qiagen N.V. is a company specializing in molecular biology technologies, providing solutions for diagnostics and research. It is listed on the Amsterdam Stock Exchange.
